Martin Wisher und Regulatory - Info zur Person

(1 - 18 von 18

)

Next Generation Sequencing and its Impact on Viral Safety Testing -...

www.mynewsdesk.com

On the 4th of June 2015, a webinar was hosted by Informa and supported by BioReliance’s Global Head of Regulatory Affairs - Dr Martin Wisher regarding next...

Keeping Up with Viral Safety Trends in Bioprocessing

www.genengnews.com

As promising as the technique is for giving more insight into potential viral contaminants, regulatory guidelines are slow to adopt.

Foundation Symposium 3 rd and 4 th April PACTpact.ac.at

www.pact.ac.at

— Bernd Jilma & Matt Moran Martin Wisher - Senior Director, Scientific & Regulatory Affairs, SAFC/BioReliance, United Kingdom:

Keeping Up with Viral Safety Trends in BioprocessingGenetic Engineering and Biotechnology News

www.genengnews.com

— Martin Wisher Ph.D., global head of regulatory affairs focusing on the BioReliance® portfolio of MilliporeSigma added that “in vivo studies ...

LinkedIn: Martin Wisher - Senior Regulatory Consultant - Merck BioReliance ...uk.linkedin.com › martin-wisher a5

View Martin Wisher's profile on LinkedIn, the world's largest professional community. Martin has 1 job listed on their profile. See the complete profile on LinkedIn ...

2019 Vaccines Process Development & Commercialization ...Massachusetts Institute of Technology

web.mit.edu

Martin Wisher, PhD view abstract | back to agenda. Senior Regulatory Consultant, Quality & Regulatory Management, MilliporeSigma.

2017 Vaccines Process Development & Commercialization Workshop

web.mit.edu

Martin Wisher, PhD view abstract | back to agenda. Head of Regulatory Affairs, BioReliance. Dr. Wisher has more than 30 years of experience in biosafety ...

Martin WisherBioPharm International

www.biopharminternational.com

Martin Wisher, PHD, is senior director, global head of regulatory affairs for BioReliance at MilliporeSigma. Articles ...

Moving your Gene Therapy from R&D to INDSlideShare

www.slideshare.net

— 15 Biosafety Risk Mitigation Strategy Martin Wisher (2018). Viral Risk Mitigation: A Global Regulatory Perspective.

Viral Risk Mitigation - A Global Regulatory Perspective

de.slideshare.net

Looking for insights into current global regulatory expectations for viral safety? Read the special report from BioProcess International, in collaboration with…

Vaccine Cell Bank and Virus Seed Characterization

de.slideshare.net

In this webinar, you will learn: - about the importance of characterising cell banks and virus seed stocks in order to meet worldwide regulatory requirements. …

January 17, 2005, Kitasato Universityv-safety.org

v-safety.org

Martin Wisher (BioReliance). Lunch Break. Session 3 Source Material Testing II ( Chairs : M. Kohase, T. Kreil ). 13:30 Regulatory Approach for Emerging ...

Development of a High Sensitivity Retrovirus Specific Reverse...

link.springer.com

The safety testing of cell substrates used to produce biological products is an important issue in the Biotechnology industry and is required by regulatory...

Simplification of Fed-Batch Processes Using Modified ...ON24

event.on24.com

Speaker - Dr Martin Wisher, Global Head of Regulatory Affairs. Abstract - Characterization of cell substrates, virus seed stocks and virus harvests, ...

Seminar, Singapore, 18th September | MilliporeSigmaEMD Millipore

www.emdmillipore.com

Martin Wisher and Michael Payne. They will discuss regulatory issues and risk reduction strategies at this inaugural event. Space is limited for this exclusive ...